Sunlenca Disease Interactions
There are 2 disease interactions with Sunlenca (lenacapavir).
Moderate
Lenacapavir (applies to Sunlenca) liver dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Lenacapavir has not been studied in patients with severe hepatic impairment (Child-Pugh Class C).
References
- (2023) "Product Information. Sunlenca (lenacapavir)." Gilead Sciences Pty Ltd, SUNLENCA Product Inf
Moderate
Lenacapavir (applies to Sunlenca) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
Lenacapavir has not been studied in patients with end stage renal disease (estimated creatinine clearance less than 15 mL per minute).
References
- (2023) "Product Information. Sunlenca (lenacapavir)." Gilead Sciences Pty Ltd, SUNLENCA Product Inf
Sunlenca drug interactions
There are 457 drug interactions with Sunlenca (lenacapavir).
Report options
QR code containing a link to this page
More about Sunlenca (lenacapavir)
- Sunlenca consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
